Science News

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the New England Journal of Medicine has published the full results of its TETON-1 study, as well as combined analyses of its TETON-1 and TETON-2 studies, evaluating the use of nebulized Tyvaso for the treatment of IPF. The publication is available here. A summary of the publication was also presented today during a symposium at th...

SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the Company will present data from the Phase 2 SOLSTICE trial evaluating the combination of tobevibart and elebsiran for chronic hepatitis delta at the upcoming EASL Congress 2026 in Barcelona, Spain, May 27-30, 2026. Efficacy and safety of tobevibart (VIR-3434) alone or in combination with elebsiran (VIR-2218) in participants with chronic hepatitis delta virus infection: Week 96 endpoint results from the Phas...

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company presented its latest research at the Oncology Nursing Society (ONS) Congress, May 13-17. The poster at ONS was titled, “Reducing Ergonomic Strain During Subcutaneous Monoclonal Antibody Administration.” The ONS abstract evaluated nur...

SAN DIEGO--(BUSINESS WIRE)--Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced that the Company will participate in the following investor conference in June. On June 4, 2026, at 12:50 p.m. Eastern Time, Raj Asarpota, Chief Financial Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference in New York City, NY. A live webcast of the fireside chat will be on th...

COLUMBUS, Ohio--(BUSINESS WIRE)--Battelle has named Katherine Palmer its Inventor of the Year, recognizing her exceptional contributions to translating cutting-edge materials science into real-world technologies that deliver meaningful societal impact. Palmer is widely recognized for solving complex “interface problems” that often determine whether a promising innovation succeeds outside the laboratory. Her work with carbon nanotube (CNT) materials has resulted in a robust intellectual property...

HAWTHORNE, Calif.--(BUSINESS WIRE)--Astrolab, an aerospace company building planetary rovers, today announced NASA payload customers for its first lunar mission aboard the company’s FLIP (FLEX Lunar Innovation Platform) rover. FLIP will fly aboard Astrobotic’s Griffin-1 lander, part of NASA’s Commercial Lunar Payload Services (CLPS) initiative. Griffin-1 will deliver payloads to the Moon’s south pole, advancing the Artemis campaign to return humans to the lunar surface. This mission is slated f...

SAN DIEGO--(BUSINESS WIRE)--Aspera Biomedicines launches second ADAR1p150 crystallization experiment to the ISS aboard SpaceX CRS-34, advancing oral Rebecsinib for 20+ cancers....

HYOGO, Japan--(BUSINESS WIRE)--JCR announced today that it presented preclinical data from its novel platform technologies in oral and poster sessions at the ASGCT Annual Meeting....

MIAMI--(BUSINESS WIRE)--Entanglement, Inc., a next-generation computing and AI company advancing quantum logic, optimization, and artificial intelligence, today announced that its Chief Research Scientist, Dr. Fred Glover, has been ranked #30 worldwide and #22 in the United States in Research.com’s 2026 Best Mathematics Scientists ranking. The fifth annual edition of the ranking evaluates more than 3,500 leading researchers across the mathematical sciences using the discipline-specific D-index,...

PALO ALTO, Calif. & MCLEAN, Va.--(BUSINESS WIRE)--Atropos Health, the world’s largest creator of real-world evidence (RWE) for clinical decision making, and Guidehouse, a global professional services firm serving the commercial and government sectors, have launched a jointly developed clinical decision support (CDS) solution designed to operationalize RWE directly within clinical workflows. The CDS solution combines Atropos Health’s predictive modeling and evidence generation capabilities with...